CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 30 filers reported holding CHAMPIONS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,110 | -2.7% | 48,488 | 0.0% | 0.07% | -4.1% |
| Q2 2023 | $309,353 | +58.7% | 48,488 | 0.0% | 0.07% | +43.1% |
| Q1 2023 | $194,922 | -19.8% | 48,488 | -10.0% | 0.05% | -28.2% |
| Q4 2022 | $243,035 | -39.8% | 53,888 | 0.0% | 0.07% | -38.3% |
| Q3 2022 | $404,000 | -20.9% | 53,888 | -15.7% | 0.12% | -22.3% |
| Q2 2022 | $511,000 | -1.5% | 63,888 | 0.0% | 0.15% | +28.7% |
| Q1 2022 | $519,000 | -23.8% | 63,888 | -21.6% | 0.12% | -16.1% |
| Q4 2021 | $681,000 | -18.1% | 81,507 | 0.0% | 0.14% | -24.3% |
| Q3 2021 | $832,000 | -14.8% | 81,507 | -14.1% | 0.18% | -11.3% |
| Q2 2021 | $976,000 | -10.6% | 94,940 | -1.8% | 0.20% | -16.0% |
| Q1 2021 | $1,092,000 | -0.3% | 96,640 | -4.7% | 0.24% | -9.0% |
| Q4 2020 | $1,095,000 | +16.2% | 101,445 | -0.4% | 0.27% | +23.0% |
| Q3 2020 | $942,000 | -14.1% | 101,848 | -11.3% | 0.22% | -24.1% |
| Q2 2020 | $1,097,000 | – | 114,769 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Battery Partners IX, LLC | 1,953,549 | $15,257,000 | 5.57% |
| PERKINS CAPITAL MANAGEMENT INC | 174,700 | $1,364,000 | 1.06% |
| EAM Global Investors LLC | 115,142 | $899,000 | 0.49% |
| NEA Management Company, LLC | 1,562,500 | $12,203,000 | 0.48% |
| EAM Investors, LLC | 196,371 | $1,534,000 | 0.42% |
| CADENCE CAPITAL MANAGEMENT LLC | 123,010 | $961,000 | 0.10% |
| Alambic Investment Management, L.P. | 27,510 | $215,000 | 0.09% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 145,850 | $1,140,000 | 0.09% |
| OBERWEIS ASSET MANAGEMENT INC/ | 37,233 | $291,000 | 0.06% |
| INGALLS & SNYDER LLC | 158,648 | $1,239,000 | 0.06% |